Financial Services

Outdoor Holding Co. ends a major legal distraction with a $4.4M payment, allowing it to fully focus on innovating its GunBroker.com marketplace.

Humane Colorado and San Francisco SPCA partner with RKD Group, signaling a major shift to data-driven strategies to boost donations and save more lives.

As AI-generated misinformation threatens corporate reputations, a digital agency is launching a new service to audit and remove harmful online content.

Georgia partners with NuHarbor Security to create a unified cyber defense, aiming to protect critical public services and citizen data across all agencies.

A Malaysian biotech's new study shows its NK cell therapy is safe, using a novel, low-cost method that could make advanced cancer treatment affordable worldwide.

Facing financial headwinds, network supplier DAVOLINK is merging with LoadRunner, pivoting to the booming but brutal AI-driven industrial automation market.

An international initiative uniting a Japanese firm, the UN, and Aikido masters empowers Los Angeles women with non-violent self-defense techniques.

Verrica Pharmaceuticals heads to a key investor conference with strong YCANTH sales, a promising pipeline for warts and skin cancer, and high expectations.

AI firm DreamzTech Solutions gains major recognition, validating its AI-first strategy and signaling a new wave of Indian tech leaders on the global stage.

As Northern Virginia home prices jump over 7%, strategic kitchen and bath renovations offer homeowners some of the highest returns on their investment.

With record results and a pivot to oil, the Calgary firm is accelerating its growth targets and challenging the status quo in Canada's prized Duvernay play.

With a novel skin drug launched, Pelthos Therapeutics heads to a key conference. Can its focused strategy convince Wall Street of its blockbuster potential?

A brief delay in Avidity's stockholder vote signals the final, complex steps before its acquisition by Novartis and the launch of a new spin-off.

ITF Therapeutics will unveil 10 new data presentations on its Duchenne therapy, DUVYZAT, offering critical new insights on long-term safety and efficacy.

With key investor conferences looming, Phathom Pharmaceuticals is set to showcase strong VOQUEZNA sales and a clear path to 2026 profitability.

After halting all R&D, PCI Biotech proposes dissolution and delisting, marking the end for its novel drug delivery platform and a warning for investors.

January data shows a massive jump in corporate financing requests, hinting at a busy year for investment, while the municipal market tells a different story.

A landmark FDA approval for Bracco's VUEWAY allows high-quality MRI scans in neonates with half the standard gadolinium dose, easing safety concerns.

A new three-tube collection system from BD promises to improve accuracy, streamline lab work, and enhance patient safety by reducing sample contamination.

Two San Diego giants join forces. Discover how 24 Hour Fitness's new partnership with the Padres aims to transform community health and youth sports.